CME Programme
-
Non-Regular Activities
SGLT2 Inhibition - From Antidiabetics Treatment to Chronic Kidney Disease ManagementDate: 11/01/2023 Enquiries: CME Department, The Hong Kong Medical Association CME Points Awarded: 1 point